These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36858148)

  • 21. Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse oximetry.
    Peterson C; Ailes E; Riehle-Colarusso T; Oster ME; Olney RS; Cassell CH; Fixler DE; Carmichael SL; Shaw GM; Gilboa SM
    JAMA Pediatr; 2014 Apr; 168(4):361-70. PubMed ID: 24493342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond Critical Congenital Heart Disease: Newborn Screening Using Pulse Oximetry for Neonatal Sepsis and Respiratory Diseases in a Middle-Income Country.
    Jawin V; Ang HL; Omar A; Thong MK
    PLoS One; 2015; 10(9):e0137580. PubMed ID: 26360420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the diagnostic gap: statewide incidence of undiagnosed critical congenital heart disease before newborn screening with pulse oximetry.
    Mouledoux JH; Walsh WF
    Pediatr Cardiol; 2013 Oct; 34(7):1680-6. PubMed ID: 23595939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn Screening for Critical Congenital Heart Disease in a Low-Resource Setting; Research Protocol and Preliminary Results of the Tanzania Pulse Oximetry Study.
    Majani N; Chillo P; Slieker MG; Sharau G; Mlawi V; Mongella S; Nkya D; Khuboja S; Kwesigabo G; Kamuhabwa A; Janabi M; Grobbee D
    Glob Heart; 2022; 17(1):32. PubMed ID: 35837363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness.
    Ewer AK; Furmston AT; Middleton LJ; Deeks JJ; Daniels JP; Pattison HM; Powell R; Roberts TE; Barton P; Auguste P; Bhoyar A; Thangaratinam S; Tonks AM; Satodia P; Deshpande S; Kumararatne B; Sivakumar S; Mupanemunda R; Khan KS
    Health Technol Assess; 2012; 16(2):v-xiii, 1-184. PubMed ID: 22284744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a Screening Program to Detect Critical Congenital Heart Defects in Newborns.
    Klausner R; Shapiro ED; Elder RW; Colson E; Loyal J
    Hosp Pediatr; 2017 Apr; 7(4):214-218. PubMed ID: 28250095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulse oximetry findings in newborns with antenatally diagnosed congenital heart disease.
    Mawson IE; Babu PL; Simpson JM; Fox GF
    Eur J Pediatr; 2018 May; 177(5):683-689. PubMed ID: 29404717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP.
    Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ; ;
    Pediatrics; 2009 Aug; 124(2):823-36. PubMed ID: 19581259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal trends in survival among infants with critical congenital heart defects.
    Oster ME; Lee KA; Honein MA; Riehle-Colarusso T; Shin M; Correa A
    Pediatrics; 2013 May; 131(5):e1502-8. PubMed ID: 23610203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Critical Congenital Heart Disease in Vermont: The Role of Universal Pulse Oximetry Screening in a Rural State.
    Good RJ; Canale SK; Goodman RL; Yeager SB
    Clin Pediatr (Phila); 2015 Jun; 54(6):570-4. PubMed ID: 25398625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Pulse Oximetry Pulsatility Index Screening for Critical Congenital Heart Disease.
    Rasmussen M; Suttner D; Poeltler D; Katheria AC
    Am J Perinatol; 2024 May; 41(S 01):e545-e549. PubMed ID: 35858650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting Critical Congenital Heart Disease in Nevada.
    Evans WN; Acherman RJ; Ciccolo ML; Lehoux J; Rothman A; Galindo A
    World J Pediatr Congenit Heart Surg; 2019 Nov; 10(6):702-706. PubMed ID: 31701835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of routine screening for critical congenital heart disease in US newborns.
    Peterson C; Grosse SD; Oster ME; Olney RS; Cassell CH
    Pediatrics; 2013 Sep; 132(3):e595-603. PubMed ID: 23918890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pulse oximetry screening of critical congenital heart defects in the neonatal period. The Spanish National Neonatal Society recommendation].
    Sánchez Luna M; Pérez Muñuzuri A; Sanz López E; Leante Castellanos JL; Benavente Fernández I; Ruiz Campillo CW; Sánchez Redondo MD; Vento Torres M; Rite Gracia S;
    An Pediatr (Engl Ed); 2018 Feb; 88(2):112.e1-112.e6. PubMed ID: 28965726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulse oximetry screening for critical congenital heart disease in planned out of hospital births and the incidence of critical congenital heart disease in the Plain community.
    Miller KK; Vig KS; Goetz EM; Spicer G; Yang AJ; Hokanson JS
    J Perinatol; 2016 Dec; 36(12):1088-1091. PubMed ID: 27583398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics.
    Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ;
    Circulation; 2009 Aug; 120(5):447-58. PubMed ID: 19581492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of critical congenital heart defects screening using pulse oximetry in the neonatal intensive care unit.
    Van Naarden Braun K; Grazel R; Koppel R; Lakshminrusimha S; Lohr J; Kumar P; Govindaswami B; Giuliano M; Cohen M; Spillane N; Jegatheesan P; McClure D; Hassinger D; Fofah O; Chandra S; Allen D; Axelrod R; Blau J; Hudome S; Assing E; Garg LF
    J Perinatol; 2017 Oct; 37(10):1117-1123. PubMed ID: 28749481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulse oximetry screening for critical congenital heart disease in planned out-of-hospital births.
    Lhost JJ; Goetz EM; Belling JD; van Roojen WM; Spicer G; Hokanson JS
    J Pediatr; 2014 Sep; 165(3):485-9. PubMed ID: 24948344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of peripheral perfusion index measurements for early detection of critical cardiac defects.
    Uygur O; Koroglu OA; Levent E; Tosyali M; Akisu M; Yalaz M; Kultursay N
    Pediatr Neonatol; 2019 Feb; 60(1):68-73. PubMed ID: 29776787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulse oximetry as a screening test for critical congenital heart disease in term newborns.
    Gómez-Rodríguez G; Quezada-Herrera A; Amador-Licona N; Carballo-Magdaleno D; Rodríguez-Mejía EJ; Guízar-Mendoza JM
    Rev Invest Clin; 2015; 67(2):130-4. PubMed ID: 25938847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.